These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB Cancer Chemother Pharmacol; 2009 Sep; 64(4):811-27. PubMed ID: 19184017 [TBL] [Abstract][Full Text] [Related]
3. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts. Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
5. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice. Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833 [TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Sun X; Zhou Z; Kang YJ Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296 [TBL] [Abstract][Full Text] [Related]
11. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. Aroui S; Brahim S; De Waard M; Bréard J; Kenani A Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity. Jean SR; Tulumello DV; Riganti C; Liyanage SU; Schimmer AD; Kelley SO ACS Chem Biol; 2015 Sep; 10(9):2007-15. PubMed ID: 26038829 [TBL] [Abstract][Full Text] [Related]
14. Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species. Kazama K; Okada M; Yamawaki H Biochem Biophys Res Commun; 2015 Feb; 457(4):602-7. PubMed ID: 25600813 [TBL] [Abstract][Full Text] [Related]
15. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Kim DS; Woo ER; Chae SW; Ha KC; Lee GH; Hong ST; Kwon DY; Kim MS; Jung YK; Kim HM; Kim HK; Kim HR; Chae HJ Life Sci; 2007 Jan; 80(4):314-23. PubMed ID: 17034819 [TBL] [Abstract][Full Text] [Related]